Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05268315 · ClinicalTrials.gov registry record · NA

A Brief Parental Intervention on Learning and Education in Childhood Cancer

A NA study of Cancer, sponsored by University of New Mexi.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT05268315: Completed NA study of Cancer, sponsored by University of New Mexi.

NCT05268315 is a NA study of Cancer that has completed, run by University of New Mexi. The registered enrollment target is 23 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05268315, a NA study of Cancer, has completed, sponsored by University of New Mexi.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess whether a brief intervention about learning and education is both practical and acceptable for parents of children with cancer.

Primary Outcome

Among qualifying families, the number receiving recruitment information about the study, identifying interest, scheduling, and completing procedures. Note, for each qualifying family, one or two parents or legal guardians are able to enroll in the study. This is a parental intervention and the child with cancer does not participate in the study.

Conditions Studied

Interventions

  • BEHAVIORAL Brief Psychoeducational Intervention

Study Locations (1)

New Mexico

  • University of New Mexico Hospital - Albuquerque

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2021-02-24
Est. Completion 2022-06-28
Phase NA
University of New Mexi

76 total trials

What the finished NCT05268315 record still lists

NCT05268315 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Brief Psychoeducational Intervention is the first listed.

NCT05268315 reports a single indexed study location in New Mexico.

Frequently Asked Questions

What is clinical trial NCT05268315 about?

NCT05268315 is a clinical study titled "A Brief Parental Intervention on Learning and Education in Childhood Cancer". The purpose of this study is to assess whether a brief intervention about learning and education is both practical and acceptable for parents of children with cancer.

What is the current status of trial NCT05268315?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2021-02-24. Estimated completion is 2022-06-28.

What conditions does trial NCT05268315 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT05268315?

The interventions under investigation include: Brief Psychoeducational Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05268315?

This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05268315 being conducted?

This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05268315's enrollment target sits among peer trials

23 548th of 615 higher than 63 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05268315, the US trial registry maintained by the National Library of Medicine. NCT05268315 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.